Literature DB >> 15090783

Lopinavir-ritonavir (Kaletra) and lithiasis: seven cases.

Thanh Doco-Lecompte, Anna Garrec, Laurent Thomas, Philippe Trechot, Thierry May, Christian Rabaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15090783     DOI： 10.1097/00002030-200403050-00022

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

Review 1.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 2.  Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.

Authors:  Zygimantas C Alsauskas; Raj Kiran Medapalli; Michael J Ross
Journal:  Expert Opin Pharmacother       Date:  2011-01-21       Impact factor: 3.889

Review 3.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

4.  Renal stone composed of ritonavir.

Authors:  Anna M Zhao; Nancy R Angoff
Journal:  BMJ Case Rep       Date:  2019-07-01

5.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

6.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

Review 7.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

8.  Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.

Authors:  Lene Ryom; Jens Dilling Lundgren; Peter Reiss; Ole Kirk; Matthew Law; Mike Ross; Phillip Morlat; Christoph Andreas Fux; Eric Fontas; Stephane De Wit; Antonella D'Arminio Monforte; Wafaa El-Sadr; Andrew Phillips; Camilla Ingrid Hatleberg; Caroline Sabin; Amanda Mocroft
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

Review 9.  HIV medication-based urolithiasis.

Authors:  Hassane Izzedine; François Xavier Lescure; Fabrice Bonnet
Journal:  Clin Kidney J       Date:  2014-03-11

10.  Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.

Authors:  Sophie Jose; Mark Nelson; Andrew Phillips; David Chadwick; Roy Trevelion; Rachael Jones; Deborah I Williams; Lisa Hamzah; Caroline A Sabin; Frank A Post
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.